Ultra-High Dose Rate Helium Ion Beams: Minimizing Brain Tissue Damage while Preserving Tumor Control
I. Dokic, M. Moustafa, T. Tessonnier, S. Meister, F. Ciamarone, M. Akbarpour, D. Krunic, T. Haberer, J. Debus, A. Mairani, A. Abdollahi
This study compares ultra-high-dose rate helium ion radiotherapy (FLASH) with standard dose rate (SDR) in mice, showing FLASH reduces brain injury and neuroinflammation while maintaining tumor control.
bioRxiv · Jun 13, 2024 · PreprintCell Biology